Peritonitis-induced antitumor activity of peritoneal macrophages from uremic patients

Folia Histochemica et Cytobiologica

Volumn 42, Issue 3, 2004, Pages 147-153

  Turyna, Bohdan ^a   Jurek, Aleksandra ^a   Gotfryd, Kamil ^a   Siaśkiewicz, Agnieszka ^a   Kubit, Piotr ^b   Klein, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

Author keywords

Activation; Antitumor activity; Macrophage, human; Peritonitis; Suramin; Taxol

Indexed keywords

PACLITAXEL; SURAMIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE ACTIVATION; PERITONEUM MACROPHAGE; PERITONITIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE; UREMIA;

EID: 4344621412     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andreesen R, Henneman B, Krause SW (1998) Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status and perspectives. J Leukoc Biol 64: 419-426
2. Ben-Efraim S (1997) Cancer immunotherapy: potential involvement of mediators. Med Inflammation 6: 164-173
3. Ben-Efraim S, Bonta IL (1994) Modulation of antitumor activity of macrophages by regulation of eicosanoids and cytokine production. Int J Immunopharmacol 16: 397-399
4. 2 and nitrite, in vitro studies. Immunol Lett 37: 27-33
5. Ben-Efraim S, Tak C, Fieren MWJA, van den Bemd GICM, Bonta IL (1991) Inflammation amplifies the antitumor cytostasis by human peritoneal macrophages. Med Oncol Tumor Pharmacother 8: 87-94
6. Bonta IL, Ben-Efraim S (1993) Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol 54: 613-626
7. Borenfreund E, Babich H (1991) Cytotoxicity of T-2 toxin and its metabolits determined with the neutral red cell viability assay. Appl Environ Microbiol 57: 2101-2103
8. Braun D, Ahn M, Harris G (1993) Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism. Cancer Res 53: 3362-3368
9. Dhar S, Gullbo J, Csoka K, Eriksson E, Nilsson K, Nickel P, Larsson R, Nygren P (2000) Antitumor activity of suramin analogues in human tumor cell lines and primary cultures of tumor cells from patients. Eur J Cancer 36: 803-809
10. Gillies RJ, Didier N, Denton M (1986) Determination of cell number in monolayer cultures. Anal Biochem 159: 109-113
11. Hamilton TA, Fishman M, Crawford G, Look AT (1983) Macrophage-mediated cytostatic activity blocks lymphoblast cell cycle progression independently in both G-1 phase and S phase. Cell Immunol 77: 33-39
12. Henneman B, Scheinbenbogen C, Schumichen C, Andreesen R (1995) Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancer. J Immunother 18: 19-27
13. Jackson PG, Evans SRT (2000) Intraperitoneal macrophages and tumor immunity: a review. J Surg Oncol 75: 146-154
14. Jindal HK, Anderson CW, Davis RG, Vishwanatha JK (1990) Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases. Cancer Res 50: 7754-7757
15. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-271
16. Mitra R, Bhaumik S, Khar A (2002) Differential modulation of host macrophage function by AK-5 tumor is dependent on the site of tumor transplantation. Immunol Lett 82: 183-190
17. Mitra R, Singh S, Khar A (2003) Antitumor immune responses. Expert Rev Mol Med 5: 1-19
18. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
19. Moss PJ, Fitzpatrick FA (1998) Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci USA 95: 3896-3901
20. Pujade-Lauraine E, Guastalla JP, Colombo N (1996) Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol 14: 343-350
21. Rago R, Mitchen J, Cheng AL, Oberley T, Wilding G (1991) Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer Res 51: 6629-6635
22. Rowisky EK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48: 353-374
23. Vaishampayan U, Parchment RE, Jasti BR, Hussain M (1999) Taxanes: an overview of the pharmacokinetics and pharmacodynamics. Urology 54, Suppl 6A: 22-29
24. Wilbanks GD, Ahn MC, Beck DA, Braun DP (1999) Tumor cytotoxicity of peritoneal macrophages and peritoneal blood monocytes from patients with ovarian, endometrial, and cervical cancer. Int J Gynecol Cancer 9: 427-432
25. Yam LT, Li CY, Crosby WH (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55: 283-290